Pharmacodynamic efficacy of two different administration routes of SLITonePLUS Birch after 4, 8, 12, 24, 36 weeks of treatment [clinicaltrials_resource:308a893ebfa3af99d1142a0a54b02e54]

Pharmacodynamic efficacy of two different administration routes of SLITonePLUS Birch after 4, 8, 12, 24, 36 weeks of treatment [clinicaltrials_resource:308a893ebfa3af99d1142a0a54b02e54]

specific antibody determination
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Primary outcome [clinicaltrials_vocabulary:primary-outcome]
http://bio2rdf.org/clinicaltrials_resource:308a893ebfa3af99d1142a0a54b02e54
Efficacy and Tolerability of Two Different Administration Routes With SLITonePLUS Birch [clinicaltrials:NCT01191359]
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

Pharmacodynamic efficacy of two different administration routes of SLITonePLUS Birch after 4, 8, 12, 24, 36 weeks of treatment [clinicaltrials_resource:308a893ebfa3af99d1142a0a54b02e54]

specific antibody determination
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Primary outcome [clinicaltrials_vocabulary:primary-outcome]
http://bio2rdf.org/clinicaltrials_resource:308a893ebfa3af99d1142a0a54b02e54
Bio2RDF identifier
308a893ebfa3af99d1142a0a54b02e54
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:308a893ebfa3af99d1142a0a54b02e54
measure [clinicaltrials_vocabulary:measure]
Pharmacodynamic efficacy of two different administration routes of SLITonePLUS Birch
time frame [clinicaltrials_vocabulary:time-frame]
after 4, 8, 12, 24, 36 weeks of treatment
description
specific antibody determination
identifier
clinicaltrials_resource:308a893ebfa3af99d1142a0a54b02e54
title
Pharmacodynamic efficacy of tw ...... 12, 24, 36 weeks of treatment
@en
inDataset
type
label
Pharmacodynamic efficacy of tw ...... a893ebfa3af99d1142a0a54b02e54]
@en